Company Sevion Therapeutics Inc OTC Bulletin Board
Equities
US81834Q1040
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Sumit Aggarwal
CEO | Chief Executive Officer | - | 21-03-31 |
Daniel Geffken
DFI | Director of Finance/CFO | 67 | 20-10-31 |
Ali Hariri
CTO | Chief Tech/Sci/R&D Officer | - | 21-09-07 |
Barbara Ryan
IRC | Investor Relations Contact | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Steven Rubin
BRD | Director/Board Member | 63 | 14-04-30 |
Alan Walts
BRD | Director/Board Member | 64 | 21-03-31 |
Sumit Aggarwal
CEO | Chief Executive Officer | - | 21-03-31 |
Lindsay Androski
BRD | Director/Board Member | - | 22-07-04 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 3,143,390 | 3,006,085 ( 95.63 %) | 0 | 95.63 % |
Company contact information
Sector
Sales per region
1st Jan change | Capi. | |
---|---|---|
-1.65% | 103B | |
+6.75% | 101B | |
+6.46% | 23.07B | |
-12.60% | 22.23B | |
-5.48% | 18.05B | |
-39.98% | 17.18B | |
-10.17% | 16.94B | |
+6.12% | 14.07B | |
+35.47% | 12.35B |
- Stock Market
- Equities
- ELOX Stock
- Stock
- Company Sevion Therapeutics Inc